Rondo Therapeutics locks in $67m Series A
Rondo Therapeutics, a biopharmaceutical company, has raised $67 million in Series A funding.
Rondo Therapeutics, a biopharmaceutical company, has raised $67 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination